MedPath

Isradipine

Isradipine Capsules, USP

Approved
Approval ID

e2f2b9a9-169f-4ccf-8974-58f21592c5bc

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Mar 9, 2012

Manufacturers
FDA

Carilion Materials Management

DUNS: 079239644

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Isradipine

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code68151-1333
Application NumberANDA077317
Product Classification
M
Marketing Category
C73584
G
Generic Name
Isradipine
Product Specifications
Route of AdministrationORAL
Effective DateMarch 12, 2012
FDA Product Classification

INGREDIENTS (12)

SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
FERRIC OXIDE YELLOWInactive
Code: EX438O2MRT
Classification: IACT
ISRADIPINEActive
Quantity: 5 mg in 1 1
Code: YO1UK1S598
Classification: ACTIB
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
ANHYDROUS LACTOSEInactive
Code: 3SY5LH9PMK
Classification: IACT
SODIUM LAURYL SULFATEInactive
Code: 368GB5141J
Classification: IACT
FERROSOFERRIC OXIDEInactive
Code: XM0M87F357
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
SHELLACInactive
Code: 46N107B71O
Classification: IACT
POTASSIUM HYDROXIDEInactive
Code: WZH3C48M4T
Classification: IACT
GELATINInactive
Code: 2G86QN327L
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Isradipine - FDA Drug Approval Details